Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

A completed Phase 2 study assessing the efficacy and safety of HB0017 in adults with moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• HB0017

Snippet

Sponsor: Huabo Biopharm Co., Ltd. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED